ALBIO — Biosynex SA Share News
0.000.00%
Last trade - 00:00- €16.48m
- €68.79m
- €95.19m
Brief: Biosynex Obtained Approval In 4 EU Countries For Its SARS-COV-2 Antigenic Self-Tests
Brief: Biosynex FY EBITDA Up At 52 Million Euros
Table: EU agrees list of COVID-19 rapid tests
Brief: Biosynex Raises 15 Million Euros In Capital Increase
Brief: Biosynex Launches Capital Increase Of Minimum EUR 8 Mln
Brief: Biosynex FY Revenue Jumps To EUR 154 Million
French and Benelux stocks-Factors to watch
Brief: BIOSYNEX Confirms FY Revenue Target
Brief: Biosynex Upgrades Its 2020 Turnover Target
Brief: Biosynex H1 Net Result Up At 6.2 Million Euros
Brief: Biosynex H1 Consolidated Revenue Up At 44.3 Million Euros
Brief: Procisedx Secures $10.5 Million Series A Financing Round Led By Biosynex, Forms An Independent Point-Of-Care Diagnostic Company
Brief: Biosynex Announces Acquisition Of A 37.17% Stake In Procisedx
Brief: Biosynex: Free Allocation Of Redeemable Share Subscription Warrants
Brief: Biosynex Says 2020 Sales To Be Boosted By COVID-19 Tests
Brief: Biosynex: COVID-19 IgG/IgM Test Authorised By Ministry Of Health
Brief: Biosynex Reinforces Production Capacities In France
Brief: Biosynex Sells All Of Its Treasury Shares For 7.25 Million Euros
Brief: Biosynex Ships First Biosynex COVID-19 BSS Tests